AMIN GILANI: Open Payments
NPI 1053674028 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 47 payments from 15 companies in 2025. Trend: 2023 $1,894 · 2024 $1,775 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $135 |
| Corium, LLC | 6 | $130 |
| Axsome Therapeutics, Inc. | 6 | $118 |
| Tris Pharma Inc | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Janssen Pharmaceuticals, Inc | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| ABBVIE INC. | 2 | $29 |
Products named: Azstarys, Auvelity, UZEDY, Dyanavel XR, CAPLYTA, SPRAVATO, COBENFY, INGREZZA.
Industry payments across AL — which companies pay providers there.
